![]() |
市場調査レポート
商品コード
1775455
医療用放射線遮蔽市場:2025年~2030年の予測Medical Radiation Shielding Market - Forecasts from 2025 to 2030 |
||||||
カスタマイズ可能
|
医療用放射線遮蔽市場:2025年~2030年の予測 |
出版日: 2025年06月27日
発行: Knowledge Sourcing Intelligence
ページ情報: 英文 140 Pages
納期: 即日から翌営業日
|
医療用放射線遮蔽市場は、CAGR 5.14%で、2025年の13億4,000万米ドルから2030年には17億2,100万米ドルに成長すると予測されます。
慢性疾患の有病率の上昇
慢性疾患、特にがんの罹患率の増加は、医療用放射線遮蔽市場の主な促進要因です。米国国立衛生研究所によると、2024年には米国だけで推定200万1,140人が新たにがんと診断され、61万1,720人が死亡しました。世界的にみても、がんは依然として死亡原因の上位を占めており、高度な画像診断と放射線治療が必要とされています。X線、CTスキャン、放射線治療などの処置には、患者や医療従事者を有害な電離放射線から守る強固な遮蔽が必要であり、遮蔽材料やソリューションの需要を牽引しています。
画像診断と放射線治療の成長
画像診断センターや放射線治療施設の拡大が市場の成長を後押ししています。米国核医学会の報告によると、疾患の早期発見と予防医療に重点を置くことで、米国では年間2,000万件近い核医学手術を含む画像診断の件数が増加しています。X線、CT、MRI、放射線治療などの診断・治療用途の急増により、病院、診断センター、歯科医院や動物病院などの専門施設における安全性を確保するための高度な遮蔽ソリューションが必要とされています。
医療従事者の健康リスク
慢性的な低線量放射線被ばくは、脳腫瘍、皮膚がん、甲状腺がん、乳がん、黒色腫、白内障、脳卒中、動脈硬化性疾患、認知機能障害などの発生率を高めるなど、医療スタッフに重大な健康リスクをもたらします。従来のリードガウンは、効果的ではあるが、かさばり、医師の身体的負担、特に腰痛を引き起こします。頭や目など遮蔽されていない部分は、脳腫瘍や白内障のリスクを高める。こうした懸念が、労働安全性を高めるための軽量で効果的な遮蔽ソリューションの技術革新を促しています。
技術革新
市場各社は、革新的な遮蔽ソリューションを通じて安全性の課題に取り組んでいます。2023年、SDS Specialist Door Solutionsは、医療施設向けに設計されたShieldoor鉛ライニングX線ドアを発売し、放射線治療施設でカスタマイズ可能な放射線防護を実現した。2023年4月、ミリオン・テクノロジーズはPTW Dosimetry社を買収し、放射線遮蔽およびモニタリングシステムのポートフォリオを強化。Radiaction Medical Ltd.は2023年4月にShield SystemのFDA 510(k)認可を取得し、この革新的な放射線防護ソリューションを米国で発売し、欧州で拡大するために1,000万米ドルを確保しました。インドでは、Advanced Materials and Processes Research Institute(CSIR-AMPRI)が鉛フリーの放射線遮蔽タイルを開発し、Atomic Energy Regulatory Board(原子力規制委員会)の認可を受け、2024年までにマハラシュトラ州のSaideep病院のX線室、CTスキャン室、カテーテルラボに2,600枚のタイルが設置されます。さらに2023年8月には、MXRイメージング社がスパルタン・シールド社を買収し、MRI室のRF、磁気、放射線防護の能力を強化しました。タングステンやビスマス合金のような鉛を含まない材料を含むこれらの進歩は、より安全で軽く、環境に優しい遮蔽ソリューションへのシフトを反映しています。
The Medical Radiation Shielding Market is expected to grow from USD 1.340 billion in 2025 to USD 1.721 billion in 2030, at a CAGR of 5.14%.
Rising Prevalence of Chronic Diseases
The increasing incidence of chronic diseases, particularly cancer, is a primary driver of the medical radiation shielding market. In 2024, an estimated 2,001,140 new cancer cases were diagnosed in the United States alone, with 611,720 deaths, according to the National Institutes of Health. Globally, cancer remains a leading cause of mortality, necessitating advanced diagnostic imaging and radiation therapy. Procedures such as X-rays, CT scans, and radiation therapy require robust shielding to protect patients and healthcare workers from harmful ionizing radiation, driving demand for shielding materials and solutions.
Growing Diagnostic Imaging and Radiation Therapy
The expansion of diagnostic imaging centers and radiation therapy facilities is fueling market growth. The emphasis on early disease detection and preventive healthcare has increased the number of imaging procedures, including nearly 20 million nuclear medicine procedures performed annually in the U.S., as reported by the Society of Nuclear Medicine. This surge in diagnostic and therapeutic applications, including X-ray, CT, MRI, and radiation therapy, necessitates advanced shielding solutions to ensure safety in hospitals, diagnostic centers, and specialized facilities like dental and veterinary clinics.
Health Risks to Medical Professionals
Chronic low-dose radiation exposure poses significant health risks to medical staff, including increased incidences of brain, skin, thyroid, and breast cancers, melanomas, cataracts, strokes, atherosclerotic disease, and cognitive impairments. Traditional lead gowns, while effective, are bulky and cause physical strain, particularly back pain, among physicians. Unshielded areas, such as the head and eyes, heighten risks of brain tumors and cataracts. These concerns are driving innovation in lightweight, effective shielding solutions to enhance occupational safety.
Technological Innovations
Market players are addressing safety challenges through innovative shielding solutions. In 2023, SDS Specialist Door Solutions launched Shieldoor lead-lined X-ray doors, designed for healthcare settings to provide customizable radiation protection in radiology facilities. In April 2023, Mirion Technologies acquired PTW Dosimetry, enhancing its portfolio of radiation shielding and monitoring systems. Radiaction Medical Ltd. received FDA 510(k) clearance in April 2023 for its Shield System, securing USD 10 million to launch this innovative radiation protection solution in the U.S. and expand in Europe. In India, the Advanced Materials and Processes Research Institute (CSIR-AMPRI) developed lead-free radiation shielding tiles, approved by the Atomic Energy Regulatory Board, with 2,600 tiles installed at Saideep Hospital in Maharashtra for X-ray rooms, CT scan rooms, and cath labs by 2024. Additionally, in August 2023, MXR Imaging Inc. acquired Spartan Shielding, bolstering its capabilities in RF, magnetic, and radiation protection for MRI rooms. These advancements, including lead-free materials like tungsten and bismuth alloys, reflect a shift toward safer, lighter, and environmentally friendly shielding solutions.
Market Segmentation
The market is segmented by product type, solution, and end-user. In 2023, the shields segment held a 41.7% market share due to its customizable protection for radiation therapy, as reported by Coherent Market Insights. X-ray shielding dominated in 2023, accounting for 45% of revenue, driven by widespread use in medical imaging, while MRI shielding is the fastest-growing segment due to increasing demand for advanced MRI technologies. Diagnostic shielding led the solution segment in 2023, but radiation therapy shielding is expected to grow rapidly, fueled by rising cancer treatments. Hospitals and diagnostic centers held the largest end-user share in 2023, with research institutes poised for significant growth.
Regional Insights
North America accounted for 37.09% of the market in 2023, driven by advanced healthcare infrastructure, high cancer prevalence, and stringent safety regulations. The U.S. performed over 80 million CT scans in 2023, necessitating robust shielding solutions. Asia-Pacific is the fastest-growing region, propelled by healthcare infrastructure investments in countries like China and India, where cancer incidence is projected to rise by 12.8% by 2025, according to the NIH.
Market Challenges
High costs of advanced shielding materials and R&D, coupled with a shortage of skilled radiologists and oncologists, pose challenges. Regulatory compliance and the environmental concerns of lead-based shielding also necessitate ongoing innovation in non-toxic alternatives.
Conclusion
The medical radiation shielding market is set to grow from USD 1.51 billion in 2024 to USD 2.5 billion by 2032, at a CAGR of 6.52%, driven by rising chronic disease prevalence, diagnostic imaging growth, and occupational safety concerns. Innovations in lead-free and lightweight shielding solutions, alongside regional healthcare investments, are key growth catalysts. However, high costs and regulatory challenges require strategic advancements to sustain market momentum.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Segmentation